<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01490541</url>
  </required_header>
  <id_info>
    <org_study_id>RP003</org_study_id>
    <nct_id>NCT01490541</nct_id>
  </id_info>
  <brief_title>The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Chulalongkorn Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Chulalongkorn Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The predictive scores for gastric cancer in gastric intestinal metaplasia(GIM) patient: a
      recommendation for Thai population.

      Objective:

      To evaluate major risk factors for gastric cancer in gastric intestinal metaplasia(GIM)
      patient in order to propose the appropriate recommendation for Thai people.

      Research Design:

      Single center, retrospective-cohort study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study population and Sample size at Faculty of Medicine, Chulalongkorn University The
      patients who were diagnosed gastric intestinal metaplasia from 1997 to 2012 and then follow
      up for 5 years. Estimate sample size =280

        -  Investigational product, dosage &amp; route of administration

        -  Questionnaire for explore the risk factors

        -  EGD with biopsy

        -  Blood sampling for gastro panel

        -  Duration of participation

        -  5 years or until diagnose gastric cancer

      Statistical method:

      Unconditional-binary-logistic regression
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence of early gastric cancer in gastric intestinal metaplasia(GIM) patient from 5 year-follow-up in Thai population</measure>
    <time_frame>Up to 5 years</time_frame>
    <description>In Thailand, gastric cancer patients usually presented with advance stage and carried the dismal prognosis. GIM is a well known precancerous lesion. The appropriate follow-up period in high risk GIM patient can increase the prevalence of early gastric cancer and reduce the mortality rate of gastric cancer</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Gastric Intestinal Metaplasia</condition>
  <arm_group>
    <arm_group_label>Gastric intestinal metaplasia patient</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All GIM patients in KCMH whose diagnosed from 1997 to 2005, at least 280.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All patients were diagnosed GIM

          2. All patients have to sign the consent form

        Exclusion Criteria:

          1. Previous gastric surgery including gastrectomy and bypass surgery

          2. Bleeding tendency including decompensated cirrhosis, chronic kidney disease and
             long-tem antiplatelets or anticoagulants

          3. HIV infection

          4. History of proton pump inhibitor use within 1 week

          5. History of antibiotic use within 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rungsun Rerknimitr, Professor</last_name>
    <role>Study Director</role>
    <affiliation>King Chulalongkorn Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rapat Pittayanon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Chulalongkron Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rapat Pittayanon, MD</last_name>
    <phone>66813132112</phone>
    <email>Rapat125@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nuttaphat Namjud, M.Sc.</last_name>
    <phone>66894971957</phone>
    <email>ampere_nut@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rapat Pittayanon</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rapat Pittayanon, MD</last_name>
      <phone>66813132112</phone>
      <email>rapat125@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Nuttapaht Namjud, M.Sc</last_name>
      <phone>66894971957</phone>
      <email>ampere_nut@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://www.medchulairb.com</url>
    <description>Ethic committee of KCMH</description>
  </link>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2011</study_first_submitted>
  <study_first_submitted_qc>December 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2011</study_first_posted>
  <last_update_submitted>June 22, 2012</last_update_submitted>
  <last_update_submitted_qc>June 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Chulalongkorn Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Rapat Pittayanon, MD</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <keyword>Gastric intestinal metaplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metaplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

